ZenGen: Transforming Precision Care in Pediatric Neurology & Psychiatry

ZenGen decodes how your child’s genes impact medication, so doctors can treat autism, ADHD, anxiety, and depression faster, with less guesswork.

gen-test-report-hero
For Physicians and Parents

Say Goodbye to Trial and Error in Medication

Physicians and parents can order a ZenGen test online and receive a comprehensive AI-powered pharmacogenomic report within three weeks. An integrated AI Co-Pilot supports clinicians in interpreting the results and identifying the most effective treatment plan for each patient.

How ZenGen Compares to Other Genetic Tests

NeuroGEN360

Other Genetics Tests

Analyzes 350+ genes and 800+ variants for drug efficacy

AI-powered pharmacogenomic report with actionable recommendations

Built-in AI Co-Pilot to assist clinicians in interpreting results and selecting treatments

Designed specifically for ADHD, axiety, autism and depression

Report turnaround in under 3 weeks

Easy-to-understand results for both physicians and parents

Significantly more affordable than most comprehensive panels

POD's exclusive pricing that is 1/10 the cost of other genetic tests

For Pediatric Physicians

Smarter, Personalized Treatment for ADHD, Autism, Anxiety & Depression

ZenGen analyzes over 350 genes and 800 variants tied to medication response, giving clinicians a deeper view than standard tests. Its AI-powered co-pilot interprets results and guides providers to faster, more precise treatment decisions for neurodevelopmental and mental health conditions.

Fewer missteps, lower costs, and more confident care.

Better Than Any Test on the Market. Here’s Proof:

Affordable Access to Precision Medicine

ZenGen delivers advanced pharmacogenomic insights at a fraction of the typical cost. By combining comprehensive gene coverage with AI-driven analysis, it makes personalized treatment more accessible without compromising clinical depth or quality.

Unmatched Genetic Coverage

With analysis of over 350 genes and 800 drug-related variants, ZenGen goes far beyond industry standards (<30 genes). This expansive scope unlocks therapeutic options previously unavailable, particularly for complex neurodevelopmental and psychiatric conditions.

AI-Powered Reports with Co-Pilot Guidance

Each report is generated using AI trained on clinical trials and real-world outcomes, then delivered with built-in Co-Pilot support. Physicians receive not just data, but actionable insights, making it easier to select the most effective medication from the start.

Faster Time to Treatment

From test to report in under three weeks, ZenGen accelerates decision-making when time matters most. Faster insights mean earlier interventions, reduced trial and error, and more timely relief for patients and families.

Join the List for
Early Access

If trial-and-error isn’t good enough for your child, you’re in the right place!